1452 related articles for article (PubMed ID: 32302438)
41. Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability.
Tan CW; Low JGH; Wong WH; Chua YY; Goh SL; Ng HJ
Am J Hematol; 2020 Jul; 95(7):E156-E158. PubMed ID: 32267008
[No Abstract] [Full Text] [Related]
42. COVID-19 and Hypercoagulability.
Sholzberg M
Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
[No Abstract] [Full Text] [Related]
43. Intra-arterial thrombosis associated with COVID-19.
Hamilton KV; Hussey KK
J Vasc Surg; 2020 Aug; 72(2):757-758. PubMed ID: 32425325
[No Abstract] [Full Text] [Related]
44. COVID-19 coagulopathy vs disseminated intravascular coagulation.
Levi M
Blood Adv; 2020 Jun; 4(12):2850. PubMed ID: 32574369
[No Abstract] [Full Text] [Related]
45. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count.
Amgalan A; Othman M
Platelets; 2020 Aug; 31(6):740-745. PubMed ID: 32456506
[TBL] [Abstract][Full Text] [Related]
46. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
[TBL] [Abstract][Full Text] [Related]
47. Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability?
De Pietri L; Montalti R; Begliomini B; Scaglioni G; Marconi G; Reggiani A; Di Benedetto F; Aiello S; Pasetto A; Rompianesi G; Gerunda GE
Eur J Anaesthesiol; 2010 Jul; 27(7):608-16. PubMed ID: 20389262
[TBL] [Abstract][Full Text] [Related]
48. COVID-19 and its implications for thrombosis and anticoagulation.
Connors JM; Levy JH
Blood; 2020 Jun; 135(23):2033-2040. PubMed ID: 32339221
[TBL] [Abstract][Full Text] [Related]
49. COVID-19 in the Healthy Patient Population: Demographic and Clinical Phenotypic Characterization and Predictors of In-Hospital Outcomes.
Ronderos Botero DM; Omar AMS; Sun HK; Mantri N; Fortuzi K; Choi Y; Adrish M; Nicu M; Bella JN; Chilimuri S
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2764-2775. PubMed ID: 32907371
[TBL] [Abstract][Full Text] [Related]
50. Thromboelastography in the evaluation of coagulation disorders in patients with sepsis.
Kiliç Y; Topçu İ; Bambal H; Civi M
Turk J Med Sci; 2014; 44(2):267-72. PubMed ID: 25536735
[TBL] [Abstract][Full Text] [Related]
51. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
Salamanna F; Maglio M; Landini MP; Fini M
Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
[TBL] [Abstract][Full Text] [Related]
52. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.
Han H; Yang L; Liu R; Liu F; Wu KL; Li J; Liu XH; Zhu CL
Clin Chem Lab Med; 2020 Jun; 58(7):1116-1120. PubMed ID: 32172226
[TBL] [Abstract][Full Text] [Related]
53. D-dimer surge and coagulation disorders in COVID-19 related pneumonia patients with cardiac injury: A case series.
Wang X; Du B; Li J; Wang S; Wang X; Guo M; Yang B; Si D; Bai O
Medicine (Baltimore); 2020 Jul; 99(31):e21513. PubMed ID: 32756189
[TBL] [Abstract][Full Text] [Related]
54. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
[TBL] [Abstract][Full Text] [Related]
55. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels.
Demelo-Rodríguez P; Cervilla-Muñoz E; Ordieres-Ortega L; Parra-Virto A; Toledano-Macías M; Toledo-Samaniego N; García-García A; García-Fernández-Bravo I; Ji Z; de-Miguel-Diez J; Álvarez-Sala-Walther LA; Del-Toro-Cervera J; Galeano-Valle F
Thromb Res; 2020 Aug; 192():23-26. PubMed ID: 32405101
[TBL] [Abstract][Full Text] [Related]
56. ISTH DIC subcommittee communication on anticoagulation in COVID-19.
Thachil J; Juffermans NP; Ranucci M; Connors JM; Warkentin TE; Ortel TL; Levi M; Iba T; Levy JH
J Thromb Haemost; 2020 Sep; 18(9):2138-2144. PubMed ID: 32881336
[TBL] [Abstract][Full Text] [Related]
57. Heparin resistance in COVID-19 patients in the intensive care unit.
White D; MacDonald S; Bull T; Hayman M; de Monteverde-Robb R; Sapsford D; Lavinio A; Varley J; Johnston A; Besser M; Thomas W
J Thromb Thrombolysis; 2020 Aug; 50(2):287-291. PubMed ID: 32445064
[TBL] [Abstract][Full Text] [Related]
58. Impact of the COVID-19 pandemic on therapeutic choices in thrombosis-hemostasis.
Hermans C; Lambert C
J Thromb Haemost; 2020 Jul; 18(7):1794-1795. PubMed ID: 32294321
[No Abstract] [Full Text] [Related]
59. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.
Viecca M; Radovanovic D; Forleo GB; Santus P
Pharmacol Res; 2020 Aug; 158():104950. PubMed ID: 32450344
[TBL] [Abstract][Full Text] [Related]
60. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.
Beun R; Kusadasi N; Sikma M; Westerink J; Huisman A
Int J Lab Hematol; 2020 Jun; 42 Suppl 1(Suppl 1):19-20. PubMed ID: 32311843
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
